Invivyd Share Rise On Positive Initial Results From CANOPY Phase 3 Trial Of VYD222
Shares of Invivyd, Inc. (IVVD) are up 148% on Monday following the announcement of positive initial results from the CANOPY Phase 3 pivotal clinical trial of VYD222.
Source: rttnews.com